VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,416,000 | +18.6% | 298,605 | +7.4% | 0.23% | -2.1% |
| Q1 2020 | $2,881,000 | +18.6% | 278,100 | +87.9% | 0.24% | +13.3% |
| Q4 2019 | $2,429,000 | +22.6% | 148,000 | -0.8% | 0.21% | +15.9% |
| Q3 2019 | $1,981,000 | +16.2% | 149,139 | +23.3% | 0.18% | +17.4% |
| Q2 2019 | $1,705,000 | +157.9% | 120,998 | +236.7% | 0.16% | +142.2% |
| Q1 2019 | $661,000 | +159.2% | 35,934 | +268.1% | 0.06% | +73.0% |
| Q4 2018 | $255,000 | -21.8% | 9,763 | -49.5% | 0.04% | -5.1% |
| Q1 2018 | $326,000 | – | 19,346 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |